|
| [2-[[(1R,2R)-2-methylcyclohexyl]carbamoylamino]-2-oxoethyl] 4-oxo-3-phenylphthalazine-1-carboxylate |
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
| Ellipticine hydrochloride |
|
Streptococcus |
Suilysin |
Preclinical (in vivo) |
Wang C, et al. 2021. Appl Environ Microbiol |
|
| ML346 |
|
Streptococcus |
Adherence |
Preclinical (in vivo) |
Guan XN, et al. 2022. RSC Med Chem |
|
| 5-Dodecanolide |
|
Streptococcus |
Biofilm; Regulation |
Preclinical (in vivo) |
Valliammai A, et al. 2020. Life Sci |
|
| N-(2-carbamoylphenyl)-5-nitro-1-benzothiophene-2-carboxamide |
|
Streptococcus |
Streptococcal glucosyltransferases |
Preclinical (in vivo) |
Nijampatnam B, et al. 2021. ACS Med Chem Lett |
|
| Lapatinib |
|
Streptococcus |
Adherence |
Preclinical (in vivo) |
Manzer HS, et al. 2022. PLoS Pathog |
|
| 5-Fluorouracil |
|
Staphylococcus
Vibrio |
Biofilm
Biofilm |
Preclinical (in vivo)
Preclinical (in vivo) |
Sedlmayer F, et al. 2021. Nucleic Acids Res
|
|
| Fursultiamin |
|
Vibrio |
HlyU |
Preclinical (in vivo) |
Imdad S, et al. 2018. Front Cell Infect Microbiol |
|
Compound 8
(internal name in literature) |
|
Vibrio |
TCP (Toxin-coregulated pilus) |
Preclinical (in vivo) |
Woodbrey AK, et al. 2018. Biochemistry |
|
| (S)-(-)-Indoline-2-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| | | |
